KLOW combines four peptides — KPV, GHK-Cu, BPC-157 and TB-500 — spanning inflammation, skin and tissue repair in a single blend.
KPV (derived from α-MSH) is the anti-inflammatory arm: in murine models it significantly reduced inflammation and sped recovery[1]. GHK-Cu adds skin remodeling — collagen, elasticity and reduced wrinkles in controlled studies[2].
BPC-157 and TB-500 complete the repair layer, accelerating cell migration and angiogenesis in preclinical research[3][4].
Supplied as a lyophilized powder for reconstitution. Figures above summarize published preclinical and cosmetic research on these molecules and are provided as scientific reference for laboratory research only.
Couldn't load pickup availability
Need reconstitution solution? Don’t forget to add Bacteriostatic Water — available as a quick add in your cart before checkout.
Advanced Quad-Peptide Blend
Four Peptides, Four Pathways: The Most Complete Regenerative Formula
KLOW combines four powerful peptides — BPC-157, TB-500, KPV, and GHK-Cu — into a single advanced research formulation. This quad blend targets tissue repair, angiogenesis, inflammation control, and cellular regeneration through complementary mechanisms. By uniting these compounds, KLOW provides the most comprehensive platform for regenerative research available.
- Quad-peptide synergy: BPC-157 + TB-500 + KPV + GHK-Cu
- 80mg total peptide per vial (10mg + 10mg + 10mg + 50mg)
- Four distinct but complementary repair pathways
- Enhanced anti-inflammatory action with KPV addition
- Streamlined protocols vs. sourcing four separate compounds
Quad-Mechanism Action
How Four Peptides Create Synergistic Regeneration
Each peptide in KLOW targets a specific phase of the healing cascade. BPC-157 drives angiogenesis and growth factor signaling. TB-500 (full 43-amino-acid Thymosin Beta-4) promotes cell migration and cytoskeletal remodeling. KPV — an α-MSH fragment — calms overactive immune signaling with potent anti-inflammatory and antimicrobial effects. GHK-Cu stimulates collagen production and tissue remodeling at the genetic level.
- BPC-157: Angiogenesis, cytoprotection, gut lining repair
- TB-500: Actin regulation, cell migration, wound healing
- KPV: Anti-inflammatory, antimicrobial, immune modulation
- GHK-Cu: Collagen synthesis, 4,000+ gene modulation
- Combined action across all stages of tissue repair
Research Applications
From Inflammation Control to Multi-System Regeneration
KLOW's unique quad-peptide design supports research across the broadest range of regenerative applications. The addition of KPV particularly enhances studies involving inflammatory conditions — from autoimmune research to gut barrier integrity. Combined with the tissue repair capabilities of the other three peptides, KLOW enables comprehensive healing pathway investigations.
- Inflammatory and autoimmune pathway research
- Gastrointestinal integrity and gut healing studies
- Tendon, ligament, and muscle repair modeling
- Wound healing and skin regeneration research
- Antimicrobial peptide activity investigations
- Comparative studies: quad vs. triple vs. single peptide
The Science Behind Quad-Peptide Synergy: Why KLOW Is the Ultimate Regenerative Platform
KLOW represents the most advanced peptide blend for regenerative research — combining four proven compounds into a single, synergistic formulation. While triple blends like GLOW offer significant advantages over single peptides, KLOW takes this further by adding KPV's powerful anti-inflammatory and antimicrobial properties.
The science behind each component is well-established. BPC-157 promotes angiogenesis, fibroblast activity, and gastrointestinal protection through growth factor signaling. TB-500 (the full 43-amino-acid Thymosin Beta-4 peptide) regulates actin — a key protein for cell movement — enabling repair cell migration to injury sites. GHK-Cu modulates over 4,000 genes related to tissue growth, collagen production, and cellular repair.
The KPV addition is what sets KLOW apart. This tripeptide fragment of α-melanocyte-stimulating hormone (α-MSH) reduces overactive immune signaling by suppressing pro-inflammatory cytokines and NF-κB activation. It also demonstrates antimicrobial activity — making KLOW particularly relevant for research involving infection, gut barrier dysfunction, or inflammatory conditions.
Together, these four peptides create an optimal healing environment: enhanced blood flow (BPC-157 + TB-500), controlled inflammation (KPV), and organized tissue remodeling (GHK-Cu). For research teams seeking the most comprehensive regenerative platform available, KLOW delivers four mechanisms in one streamlined formulation.
For research use only. Not for human consumption.
Scientific Literature
- Kannengiesser K, Maaser C, Heidemann J, Luegering A, Ross M, Brzoska T, Bohm M, Luger TA, Domschke W, Kucharzik T. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis. 2008 Mar;14(3):324-31.
- Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-88.
- Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985). 2011;110(3):774-80.
- Malinda KM, Goldstein AL, Kleinman HK. Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. FASEB J. 1997;11(6):474-81.
Packaged with care, shipped fast.
The Qovigen Difference
KLOW – 80 mg — Qovigen vs. a typical supplier.
Qovigen
KLOW – 80 mg
Qovigen Peptides
Competitor
KLOW – 80 mg
Typical Competitor
01 /
Higher Purity
02 /
Better Price
03 /
Faster Shipping
04 /
Verified Quality
After testing more than $8,500 worth of vials over the past year, Qovigen ranks first — set apart by genuinely new production technology.
Dr Aimen Arij
Doctor of Pharmacology · Lead Writer, dosagepeptide.com